This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Anxiety Depression and Rheumatoid Arthritis (ADAR)

This study is not yet open for participant recruitment.
See Contacts and Locations
Verified April 2017 by Kun Zou, Sichuan Provincial People's Hospital
Sponsor:
Information provided by (Responsible Party):
Kun Zou, Sichuan Provincial People's Hospital
ClinicalTrials.gov Identifier:
NCT03061877
First received: February 20, 2017
Last updated: April 24, 2017
Last verified: April 2017
  Purpose
Anxiety and depression are highly prevalent in people with rheumatoid arthritis (RA).This study is to investigate the effect of anxiety and depression on treatment response in people with RA using observational longitudinal study design.

Condition Intervention
Rheumatoid Arthritis Other: Anxiety or depression

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: The Effect of Anxiety and Depression on Treatment Response in Rheumatoid Arthritis

Resource links provided by NLM:


Further study details as provided by Kun Zou, Sichuan Provincial People's Hospital:

Primary Outcome Measures:
  • Clinical remission [ Time Frame: 6 months ]
    Clinical remission defined by the Disease Activity Score 28 (DAS28) with a score less than 2.6


Estimated Enrollment: 134
Anticipated Study Start Date: September 2017
Estimated Study Completion Date: December 2019
Estimated Primary Completion Date: March 2019 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
Anxiety or depression Other: Anxiety or depression
The presence of anxiety or depression measured by the Hospital Anxiety and Depression Scale (HAD)
Non-anxiety or depression

  Eligibility

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
People diagnosed with rheumatoid arthritis according to American College Rheumatology (ACR) criteria 2010
Criteria

Inclusion Criteria:

  • People diagnosed with rheumatoid arthritis according to the American College Rheumatology (ACR) criteria 2010

Exclusion Criteria:

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT03061877

Contacts
Contact: Kun Zou, PhD 86 028-87393972 zoukun.jy@outlook.com

Sponsors and Collaborators
Sichuan Provincial People's Hospital
Investigators
Principal Investigator: Kun Zou, PhD Sichuan Provincial People's Hospital
  More Information

Responsible Party: Kun Zou, PhD, Sichuan Provincial People's Hospital
ClinicalTrials.gov Identifier: NCT03061877     History of Changes
Other Study ID Numbers: SichuanPPH201701
Study First Received: February 20, 2017
Last Updated: April 24, 2017

Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Keywords provided by Kun Zou, Sichuan Provincial People's Hospital:
Rheumatoid arthritis
Anxiety
Depression

Additional relevant MeSH terms:
Depression
Arthritis
Arthritis, Rheumatoid
Behavioral Symptoms
Joint Diseases
Musculoskeletal Diseases
Rheumatic Diseases
Connective Tissue Diseases
Autoimmune Diseases
Immune System Diseases

ClinicalTrials.gov processed this record on September 25, 2017